Europe hemoglobinopathies market has been gaining traction in recent years, driven by increasing awareness, advancements in treatment options, and supportive healthcare policies. Hemoglobinopathies, a group of inherited blood disorders, include conditions such as thalassemia and sickle cell anaemia. These disorders impact haemoglobin, the molecule responsible for oxygen transport...

The Latin America generic drugs market has been gaining considerable momentum in recent years. Valued at USD 36.1 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 6.33% between 2024 and 2032, reaching an estimated USD 62.7 billion by the end of the forecast period. This growth is fuelled by a combination of increasing government support, expanding...

Cell and gene therapy are redefining the landscape of healthcare, offering curative treatments for conditions once deemed incurable. By targeting the root causes of genetic and cellular disorders, these therapies promise breakthroughs in treating cancer, rare genetic diseases, and degenerative disorders. In 2023, the global cell and gene therapy market was valued at an impressive USD...

Sickle cell disease (SCD) is a life-threatening genetic blood disorder that impacts millions of people worldwide. Characterised by abnormally shaped red blood cells that disrupt normal blood flow, SCD leads to painful episodes, organ damage, and can reduce life expectancy. According to the World Health Organization, SCD is particularly prevalent in sub-Saharan Africa, India, and the Middle...

Microdermabrasion, once an exclusive treatment available only at dermatology clinics, has evolved into a popular skincare solution accessible to consumers worldwide. With the increasing demand for minimally invasive cosmetic procedures, the global microdermabrasion devices market has experienced significant growth. Valued at USD 590.38 billion in 2023, this market is set to expand at a CAGR of...

Obesity remains a pressing public health challenge in North America, with rates steadily climbing and driving the demand for innovative and effective anti-obesity treatments. According to projections, the North American anti-obesity drugs market is set to grow at an impressive compound annual growth rate (CAGR) of 9.30% from 2024 to 2032. This growth is attributed to a...

The cell therapy market has been witnessing remarkable growth, reflecting a paradigm shift in medical science. Valued at USD 16.30 billion in 2023, the market is set to grow at a robust CAGR of 18.1%, reaching USD 72.84 billion by 2032. This rapid expansion is fuelled by an increasing global burden of chronic diseases, significant investments in cell therapy research, and rising clinical trial...

The healthcare industry in India has seen remarkable advancements, with an increased focus on infection control and hygiene. Disposable surgical wear, a critical component in maintaining sterile environments, has witnessed a substantial surge in demand. In 2023, the India disposable surgical wear market was valued at approximately INR 10,107.10 crore. Projections suggest this market will grow...

The pharmacy management system market, valued at USD 43.04 billion in 2023, is on a trajectory to reach a staggering USD 99.84 billion by 2032, with a projected CAGR of 9.8% during the forecast period of 2024-2032. This robust growth is driven by the rising demand for efficiency in pharmacy operations, advancements in healthcare IT, and the need for reducing medication...

The United States reading glasses market is poised for significant growth, with a projected CAGR of 5.40% between 2024 and 2032. As the population ages and the prevalence of presbyopia rises, reading glasses are becoming an essential product for a large segment of the population. In addition to their functional role, reading glasses have evolved into a style statement, attracting consumers who...